Skip to main content

Advertisement

SpringerLink
Log in

Hypercalcitoninemia in thyroid conditions other than medullary thyroid carcinoma: a comparative analysis of calcium and pentagastrin stimulation of serum calcitonin

  • Original Article
  • Published:
Langenbeck's Archives of Surgery Aims and scope Submit manuscript

Abstract

Purpose

Calcitonin screening aims at uncovering occult medullary thyroid cancer (MTC) in patients with nodular thyroid disease. Elevated basal calcitonin serum levels call for calcitonin stimulation, the level of which may direct the extent of surgery. Because pentagastrin has become restricted, calcium has increasingly been used instead for stimulation. This study identified a new spectrum of patients demonstrating a false-positive hypercalcitoninemia in the absence of C-cell disease, carrying multinodular goiter (MNG), thyroiditis, and non-MTC thyroid malignancy, and endeavored to explore the feasibility of extrapolating pentagastrin-stimulated to calcium-stimulated calcitonin thresholds.

Methods

Altogether, 43 (9.5 %) of 455 patients with nodular thyroid disease revealed increased basal calcitonin serum levels between 2005 and 2012, for which they underwent intravenous stimulation with pentagastrin (31 patients) or calcium gluconate (12 patients) before and after primary thyroidectomy.

Results

Stimulation with calcium gluconate resulted in significantly higher and more variable preoperative calcitonin serum levels after 2 (241.2 vs. 104.9 pg/mL; P = 0.018) and 5 min (240.6 vs. 87.4 pg/mL; P = 0.007) than stimulation with pentagastrin. Stimulation with calcium gluconate produced 10-fold (nodular goiter), 15-fold (thyroiditis), and 21-fold (thyroid neoplasia other than MTC) calcitonin increases over baseline, as opposed to 5-fold, 10-fold, and 8-fold increases after stimulation with pentagastrin. None of the 43 patients, all of whom reverted to undetectable calcitonin serum levels after thyroidectomy, had immunohistochemical evidence of C-cell disease. Subgroup analyses according to gender and thyroid disease, being limited by the low number of patients in each subgroup, did not yield significant differences.

Conclusions

Calcium stimulation yields significantly greater calcitonin levels than pentagastrin stimulation, precluding generalization of pentagastrin-stimulated to calcium-stimulated calcitonin thresholds. After calcium stimulation, false-positive findings appear to be more common in patients of female gender and patients with thyroiditis and thyroid neoplasia other than MTC, potentially effecting surgical overtreatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Cohen R, Campos JM, Salaün C, Heshmati HM, Kraimps JL, Proye C, Sarfati E, Henry JF, Niccoli-Sire P, Modigliani E (2000) Preoperative calcitonin levels are predictive of tumor size and postoperative calcitonin normalization in medullary thyroid carcinoma. Groupe d’Etudes des Tumeurs a Calcitonine (GETC). J Clin Endocrinol Metab 85:919–922

    Article  PubMed  CAS  Google Scholar 

  2. Cooper CW, Schwesinger W, Ontjes D, Mahgoub A, Munson P (1971) Stimulation of secretion of pig thyrocalcitonin by gastrin and related hormonal peptides. Science 18:1238–1240

    Article  Google Scholar 

  3. Hennessy JF, Gray TK, Cooper CW, Ontjes DA (1973) Stimulation of thyrocalcitonin secretion by pentagastrin and calcium in two patients with MTC. J Clin Endocrinol Metab 36:200–203

    Article  PubMed  CAS  Google Scholar 

  4. Hennessy JF, Wells SA, Ontjes DA, Cooper CW (1974) A comparison of pentagastrin injection and calcium infusion as provocative agents for the detection of MTC. J Clin Endocrinol Metab 39:487–495

    Article  PubMed  CAS  Google Scholar 

  5. Parthemore JG, Bronzert D, Roberts G, Deftos LJ (1974) A short calcium infusion in the diagnosis of medullary thyroid carcinoma. J Clin Endocrinol Metab 39:108–111

    Article  PubMed  CAS  Google Scholar 

  6. Rude RK, Singer FR (1976) Comparison of serum calcitonin levels after a 1-minute calcium injection and after pentagastrin in the diagnosis of MTC. J Clin Endocrinol Metab 44:980–983

    Article  Google Scholar 

  7. Parthemore JG, Deftos LJ (1978) Calcitonin secretion in primary hyperparathyroidism. J Clin Endocrinol Metab 49:223–226

    Google Scholar 

  8. Wells SA, Baylin S, Gann D, Farrell R, Dilley W, Preissig S, Linehan WM, Cooper CW (1978) Medullary thyroid carcinoma: relationship of method of diagnosis to pathologic staging. Ann Surg 188:377–383

    Article  PubMed  Google Scholar 

  9. Doyle P, Düren C, Nerlich K, Verburg FA, Grelle I, Jahn H, Fassnacht M, Mäder U, Reiners C, Luster M (2009) Potency and tolerance of calcitonin stimulation with high-dose calcium versus pentagastrin in normal adults. J Clin Endocrinol Metab 94:2970–2974

    Article  PubMed  CAS  Google Scholar 

  10. Kudo T, Miyauchi A, Ito Y, Yabuta T, Inoue H, Higashiyama T, Tomoda C, Hirokawa M, Amino N (2011) Serum calcitonin levels with calcium loading tests before and after total thyroidectomy in patients with thyroid diseases other than medullary thyroid carcinoma. Endocr J 58:217–221

    Article  PubMed  CAS  Google Scholar 

  11. Colombo C, Verga U, Mian C, Ferrero S, Perrino M, Vicentini L, Dazzi D, Opocher G, Pelizzo MR, Beck-Peccoz P, Fugazzola L (2011) Comparison of calcium and pentagastrin tests for the diagnosis and follow-up of medullary thyroid cancer. J Clin Endocrinol Metab 97:905–913

    Article  PubMed  Google Scholar 

  12. McLean GW, Rabin D, Moore L, Deftos LJ, Lorber D, McKenna TJ (1984) Evaluation of provocative test in suspected medullary carcinoma of the thyroid: heterogeneity of calcitonin responses to calcium and pentagastrin. Metabolism 33:790–796

    Article  PubMed  CAS  Google Scholar 

  13. Erdoğan MF, Güllü S, Başkal N, Uysal AR, Kamel N, Erdoğan G (1997) Omeprazole: calcium stimulation test for the diagnosis, follow-up and screening of MTC. J Clin Endocrinol Metab 82:897–899

    Article  PubMed  Google Scholar 

  14. Vitale G, Ciccarelli A, Caraglia M, Galderisi M, Rossi R, Del Prete S, Abbruzzese A, Lupoli G (2002) Comparison of two provocative tests for calcitonin in MTC: omeprazole vs. pentagastrin. Clin Chem 48:1505–1510

    PubMed  CAS  Google Scholar 

  15. Cohen SL, MacIntyre I, Grahame-Smith D, Walker JG (1973) Alcohol-stimulated calcitonin release in MTC. Lancet 24:1172–1173

    Article  Google Scholar 

  16. Wells SA Jr, Cooper CW, Ontjes DA (1975) Stimulation of thyrocalcitonin secretion by ethanol in patients with medullary thyroid carcinoma—an effect apparently not mediated by gastrin. Metabolism 24:1215–1219

    Article  PubMed  Google Scholar 

  17. Karges W, Dralle H, Raue F, Mann K, Reiners C, Grussendorf M, Hüfner M, Niederle B, Brabant G (2004) Calcitonin measurement to detect medullary thyroid carcinoma in nodular goiter: German evidence-based consensus recommendation. Exp Clin Endocrinol Diabetes 112:52–58

    Article  PubMed  CAS  Google Scholar 

  18. Toledo SP, Lourenço DM Jr, Santos MA, Tavares MR, Toledo RA, Correia-Deur JE (2009) Hypercalcitoninemia is not pathognomonic of medullary thyroid carcinoma. Clinics 64:699–706

    Article  PubMed  Google Scholar 

  19. Pacini F, Schlumberger M, Dralle H, Ilisea R, Smith Y, Viersinga V (2006) European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol 155:385–389

    Article  CAS  Google Scholar 

  20. Vierhapper H, Niederle B, Bieglmayer C, Kaserer K, Baumgartner-Parzer S (2005) Early diagnosis and curative therapy of medullary thyroid carcinoma by routine measurement of serum calcitonin in patients with thyroid disorders. Thyroid 15:1267–1272

    Article  PubMed  CAS  Google Scholar 

  21. The International Agency for Research on Cancer, DeLellis R, Lloyd R, Heitz P, Eng C (2004) World Health Organization classification of tumours. Pathology and genetics of tumours of endocrine organs. IARC, Lyon

    Google Scholar 

  22. Gibelin H, Essique D, Jones C, Levillain P, Maréchaud R, Kraimps JL (2005) Increased calcitonin level in thyroid nodules without medullary carcinoma. Br J Surg 92:574–578

    Article  PubMed  CAS  Google Scholar 

  23. Palestini N, Borasi A, Cestino L, Freddi M, Odasso C, Robecchi A (2008) Is central neck dissection a safe procedure in the treatment of papillary thyroid cancer? Our experience. Langenbeck's Arch Surg 393:693–698

    Article  CAS  Google Scholar 

  24. Wong KP, Lang BH (2011) The role of prophylactic central neck dissection in differentiated thyroid carcinoma: issues and controversies. J Oncol 127929

  25. Machens A, Dralle H (2012) Biological relevance of medullary thyroid microcarcinoma. J Clin Endocrinol Metab 97:1547–1553

    Article  PubMed  CAS  Google Scholar 

  26. Machens A, Hoffmann F, Sekulla C, Dralle H (2009) Importance of gender-specific calcitonin thresholds in screening for occult sporadic medullary thyroid cancer. Endocr Relat Cancer 16:1291–1298

    Article  PubMed  CAS  Google Scholar 

  27. Reubi JC, Schaer JC, Waser B (1997) Cholecystokinin (CCK)-A and CCK-B/gastrin receptors in human tumors. Cancer Res 57:1377–1386

    PubMed  CAS  Google Scholar 

  28. Behr TM, Béhé MP (2002) Cholecystokinin-B/gastrin receptor-targeting peptides for staging and therapy of medullary thyroid cancer and other cholecystokinin-B receptor-expressing malignancies. Semin Nucl Med 32:97–109

    Article  PubMed  Google Scholar 

Download references

Conflicts of interest

None.

Author information

Authors and Affiliations

  1. Department of General, Visceral, and Vascular Surgery, University of Halle-Wittenberg, Halle, Germany

    Kerstin Lorenz, Malik Elwerr, Andreas Machens, Mohammed Abuazab & Henning Dralle

  2. Department of Pathology, University of Halle-Wittenberg, Halle, Germany

    Hans-Jürgen Holzhausen

Authors
  1. Kerstin Lorenz
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Malik Elwerr
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Andreas Machens
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Mohammed Abuazab
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Hans-Jürgen Holzhausen
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Henning Dralle
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kerstin Lorenz.

Additional information

Kerstin Lorenz and Malik Elwerr contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lorenz, K., Elwerr, M., Machens, A. et al. Hypercalcitoninemia in thyroid conditions other than medullary thyroid carcinoma: a comparative analysis of calcium and pentagastrin stimulation of serum calcitonin. Langenbecks Arch Surg 398, 403–409 (2013). https://doi.org/10.1007/s00423-013-1049-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00423-013-1049-6

Keywords

Search

Navigation